About this episode

Dr. Christopher Kramer discusses the impact of GLP-1 and GIP therapies on cardiovascular health and obesity-related heart failure.

In this episode of The GLP-1 Podcast Show, I speak with Dr. Christopher Kramer, Chief of the Cardiovascular Division at the University of Virginia Health, about how GLP-1 and GIP therapies are reshaping the treatment of obesity-related heart failure. We explore cardiac remodeling, adipose tissue reduction, cardiovascular outcomes, and the mechanisms behind improved patient health. Listen now on all major platforms! "Treatment with tirzepatide reduced heart failure events by approximately fifty percent while helping patients feel better and perform daily activities more comfortably." Meet the guest: Dr. Christopher Kramer https://www.linkedin.com/in/christopher-kramer-55200931/ earned his A.B. from Harvard and his M.D. from UCSF before completing cardiology training at the University of Pennsylvania. He is the George A. Beller, MD/Lantheus Medical Imaging Distinguished Professor of Cardiovascular Medicine and Chief of the Cardiovascular Division at the University of Virginia Health. His research focuses on cardiovascular magnetic resonance imaging and heart disease. Listen to Dr. Christopher Kramer on The GLP-1 Podcast Show, available on all major platforms. What you will learn…

People in this episode

Host: Wisenetix

Guest: Dr. Christopher Kramer

Topics covered

• cardiovascular health
• GLP-1 therapies
• obesity-related heart failure
• cardiac remodeling
• adipose tissue reduction
• patient health

Keywords

• GLP-1
• GIP
• tirzepatide
• heart failure
• cardiac remodeling
• adipose tissue
• patient outcomes
• weight loss
• cardiovascular health

Mentioned in this episode

Organizations: University of Virginia Health, Harvard, UCSF, University of Pennsylvania, Lantheus Medical Imaging

Products: tirzepatide

More episodes of The GLP-1 Podcast Show

• Dr. Ashley Koff: Weight Health in the GLP-1 Era | Ep. 13 · September 7, 2026 · 35 min
• Dr. Timothy Garvey: Adiposity-Based Chronic Disease Explained | Ep. 12 · August 24, 2026 · 34 min
• Dr. Richard DiMarchi: The Evolution of GLP-1 Science | Ep. 10 · July 6, 2026 · 33 min
• Dr. Sandra Christensen: Preserving Muscle During GLP-1 Treatment | Ep. 09 · June 1, 2026 · 30 min
• Dr. Jason Itri: GLP-1 Microdosing Strategy | Ep. 08 · May 4, 2026 · 33 min
• Dr. Catherine Toomer: GLP-1 Dosing Strategy | Ep. 07 · April 6, 2026 · 29 min

Explore listener stats, chart rankings, contacts and more on the The GLP-1 Podcast Show podcast page.